City page
Uppsala biotech and pharma directory
This page shows why the city matters, which categories are strongest there, and which compliance or quality markers are already visible in public evidence.
Where does this city read strongest?
Therapeutics (2), Tools (1), and Diagnostics (1). Most visible records: Abera Bioscience, Orexo, and Biovica.
Which standards and public evidence are already visible?
FDA-Inspected (1). Latest review: 21 March 2026. Review cycle: March 2026.
Why does this city matter?
This page brings visible companies and infrastructure records into one practical view of Uppsala.
By category
Uppsala by category
Jump into a category page filtered to this country only.
Full list
Uppsala biotech and pharma directory
4 city records currently match the active filter.
Current review cycle
Abera Bioscience
UppsalaSwedenTherapeutics
Uppsala vaccine-development company building next-generation nasal vaccines on an OMV platform, with its own Swedish laboratory and product-development base.
- Lead
- Maria AlrikssonCEO
- Scale
- Development-stage vaccine platform
Current review cycle
Orexo
UppsalaSwedenTherapeutics
Uppsala pharmaceutical company developing improved drug products and formulation-based therapeutics, with Swedish R&D and headquarters operations in Uppsala.
- Lead
- Nikolaj SorensenPresident and CEO
- Scale
- Development-stage pharmaceutical platform
Current review cycle
Biovica
UppsalaSwedenDiagnostics
Uppsala diagnostics company focused on blood-based cancer monitoring and biomarker testing through the DiviTum platform.
- Lead
- Anders RylanderCEO
- Scale
- Commercial diagnostics platform
Current review cycle
Biotage AB
UppsalaSwedenTools
Uppsala life-science tools company building purification, synthesis, and analytical workflow systems for drug discovery, peptide chemistry, and sample preparation labs.
- Lead
- Frederic VanderhaegenChief Executive Officer
- Scale
- Industrial Tools
Related briefs
Briefs that mention Uppsala
Nordic Biotech Landscape 2026: Denmark, Sweden, Finland, Norway
A practical map of the Nordic biotech and pharma landscape in 2026 — 124 operators across Denmark, Sweden, Finland, and Norway, anchored by Novo Nordisk, Genmab, Lundbeck, AstraZeneca Gothenburg, Bavarian Nordic, Orion, and a dense Medicon Valley + Karolinska cluster layer.
Open briefEuropean Vaccines Landscape 2026: Biodefence, mRNA, Allergen, Infectious Disease
A practical map of the European vaccines sector in 2026 — Bavarian Nordic MVA-BN biodefence, BioNTech and CureVac mRNA, ALK-Abelló allergen immunotherapy, Valneva infectious-disease vaccines, Statens Serum Institut, plus a specialised clinical-stage innovator layer.
Open briefEuropean Drug Discovery Services 2026: CRO, Medicinal Chemistry, ADMET, DMPK
Where to run European drug discovery services in 2026 — Evotec, Selvita, Charles River Finland, Gubra, Admescope, plus a Swiss + Polish + Nordic tool + platform layer for medicinal chemistry, DMPK, ADMET, and translational research.
Open briefNext step
Read the city, then widen the view.
Use country and regional pages for wider context, and the company suggestion form for new candidate records.